Anlotinib Enhances the Therapeutic Effect of Bladder Cancer with GSDMB Expression: Analyzed from TCGA Bladder Cancer Database & Mouse Bladder Cancer Cell Line.

Wang, Chen; Cao, Qifeng; Zhang, Shun; Liu, Hailong; Duan, Huangqi; Xia, Weimin; Shen, Haibo; Wang, Cheng

Wang, Chen; Cao, Qifeng; Zhang, Shun; Liu, Hailong; Duan, Huangqi; Xia, Weimin; Shen, Haibo; Wang, Cheng.

Afiliação

Wang C; Department of Urology, The People's Hospital of SND, Suzhou, People's Republic of China.
Cao Q; Department of Urology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
Zhang S; Department of Urology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
Liu H; Department of Urology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
Duan H; Department of Urology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
Xia W; Department of Urology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
Shen H; Department of Urology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
Wang C; Department of Urology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.

Pharmgenomics Pers Med ; 16: 219-228, 2023.

Article em En | MEDLINE | ID: mdl-36960215